To access this feature, please Log In or Register for your Casebriefs Account.

Add to Library




Daubert v. Merrell Dow Pharmaceuticals, Inc

Law Dictionary

Law Dictionary

Featuring Black's Law Dictionary 2nd Ed.
Font size

Torts Keyed to Prosser

Citation. Daubert v. Merrell Dow Pharms., Inc., 509 U.S. 579, 113 S. Ct. 2786, 125 L. Ed. 2d 469, 1993 U.S. LEXIS 4408, 27 U.S.P.Q.2D (BNA) 1200, 61 U.S.L.W. 4805, 93 Cal. Daily Op. Service 4825, 93 Daily Journal DAR 8148, 23 ELR 20979, CCH Prod. Liab. Rep. P13,494, 7 Fla. L. Weekly Fed. S 632 (U.S. June 28, 1993)

Brief Fact Summary. The Plaintiffs, Daubert and other minors (Plaintiffs), suffered limb reduction birth defects. They claim the defects were caused when their mothers ingested drugs manufactured by the Defendant, Merrell Dow Pharmaceuticals, Inc. (Defendant), while they were pregnant.

Synopsis of Rule of Law. To be admissible, expert scientific testimony that is derived from research done for the purpose of litigation must show that the conclusions were reached after following recognized scientific methods of research.

Facts. The minor Plaintiffs were injured when their mothers ingested drugs manufactured by the Defendant. According to the Plaintiffs’ experts, the drug manufactured by the Defendant caused the deformities. However, the majority of the scientific field does not agree that the drug causes limb deformities and the Federal Drug Authority (FDA) continues to approve of its use in pregnant women.

Issue. Whether the expert testimony offered by the Plaintiffs is admissible.
See More Course Videos

Create New Group

Casebriefs is concerned with your security, please complete the following